New funding enables healthŌme to enhance its
genomics-based precision health offerings in the life and critical
illness insurance sectors.
HUNTSVILLE, Ala., May 22, 2024
/PRNewswire/ -- healthŌme®, Inc., a
leading genomics-based, precision health management company, today
announced the successful closure of its Preferred Seed Funding
round led by American Family Ventures (AFV) and AllegisNL
Capital. This investment substantially boosts healthŌme's
ability to expand its product and service offerings, strengthening
its position at the forefront of delivering precision medicine and
genomics-driven health solutions to the life and critical illness
insurance markets.
healthŌme has also announced the appointment of two
distinguished members to its board of directors. Brittany Clements, Managing Director at American
Family Ventures, and Spencer Tall,
Managing Director at AllegisNL Capital, join as new members.
Additionally, Julian Whitekus, Vice
President and experienced actuary from Hannover Re America, will
continue his role as a Board Observer.
"This investment, along with our expanded board, bolsters our
ability to enhance long-term company value and cultivate
market-leading precision medicine solutions for the critical
illness and life insurance sectors," said Darren Rowe, Chief Executive Officer of
healthŌme. "The leadership and support that Brittany and Spencer
bring to our shared vision of providing innovative living benefits
places our team on an optimal path to create an exceptional and
elevated health management experience. We couldn't be more pleased
to welcome them to the board."
The funding boosts healthŌme's ability to bolster its
operational infrastructure, elevate its offerings, and launch
additional cutting-edge programs for critical illness and life
insurance carriers. healthŌme's programs deliver value to carriers
by increasing policyholder engagement and persistency while driving
better health outcomes and decreased mortality.
healthŌme, a precision health and disease management leader,
provides its policyholders with genomics-based precision health
navigation and management services. By initially focusing on cancer
management and pharmacogenomics, healthŌme delivers personalized
solutions that improve health outcomes for their policyholders.
Their services provide day-one proactive health management benefits
via Pharmacogenomic Testing, Medication Safety Management Programs,
Hereditary Cancer Risk Screening, and genetic counseling. Upon a
cancer diagnosis, a precision cancer management program utilizes
comprehensive post-diagnostic genomic profiling to provide crucial
treatment guidance, 1:1 Oncology Nurse Navigation, and clinical
trial identification and enrollment. Cancer survivorship and
recovery services are also provided through DNA-based recurrence
monitoring and continuing Oncology Nurse Navigation support.
healthŌme's key seed investors, American Family Ventures and
AllegisNL Capital, are recognized for their strategic investments
in early-stage startups poised to disrupt traditional paradigms in
the insurance sector. Their investment in healthŌme reflects their
ongoing commitment to fostering innovations to reshape the biotech,
insurtech, and life insurance landscapes.
"We are proud to partner with healthŌme as they bring
advancements to insurtech, putting the life back into life
insurance in a tenacious way that we've not seen before," said
Brittany Clements, Managing Director
at American Family Ventures and healthŌme board member.
"healthŌme's partnership with carriers can offer financial benefits
or protection alongside services and solutions that can drive
positive outcomes and assist individuals navigating challenging
events. We believe their model fundamentally challenges the status
quo of genomics-based disease management in life insurance."
Spencer Tall, Managing Director
at AllegisNL Capital and healthŌme board member, remarked, "The
nexus of technology, life insurance, and precision medicine
presents significant opportunities for modernization. We believe
that healthŌme's initiatives in genomic testing and precision
healthcare could be game-changers in transforming the current
landscape of the life insurance living benefits sector."
About healthŌme, Inc.
healthŌme, Inc. is a
genomics-based, precision-health navigation company operating at
the intersection of life insurance, life science, and health
management. With a fully integrated, in-house genetics lab,
healthŌme is dedicated to simplifying and accelerating access to
technologies and services that can dramatically alter an
individual's health trajectory, with an initial focus on cancer.
healthŌme, in partnership with Hannover Re US, the reinsurer for
healthŌme's first-of-its-kind cancer management program,
designs and delivers tech-enabled, precision health management
solutions through a network of life and critical insurance
carriers. healthŌme and its subsidiary, Kailos Genetics, are based
at the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama. To learn more, visit
www.healthome.com, and stay connected on LinkedIn.
About AllegisNL Capital
AllegisNL Capital is a leading
venture capital (VC) firm with a track record of more than 20 years
since its establishment in 1996 and is positioned as Top VC with
more than USD 2 bln of total assets
under management over its entire platform. Allegis has a track
record in establishing more than 10 funds, mainly in the fields of
general technology, cyber security, and data science. To learn
more, www.allegiscapital.com.
About American Family Ventures
American Family
Ventures is a venture capital firm focused on insurance innovation.
Founded in 2013, AFV invests in early-stage startups that are
redefining the future of the insurance industry. AFV aims to help
create category-leading companies through minority equity
investments, active partnership and collaboration, an extensive
insurtech network, an industry-spanning Limited Partner syndicate,
and a comprehensive platform of value-add programs. To learn more,
visit www.amfamventures.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/healthme-closes-preferred-seed-financing-in-round-led-by-american-family-ventures-and-allegisnl-capital-302152333.html
SOURCE healthŌme, Inc.